0O1O.L
Vetoquinol S.A.
1W: -2.3%
1M: -10.2%
3M: +7.3%
YTD: -10.5%
1Y: +2.1%
3Y: -1.9%
€77.50 ($89.28)
-1.10 (-1.40%)
Weekly Expected Move ±5.0%
€69
€73
€77
€80
€84
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap€914.5M ($1.1B)
52W Range76.6-108.99401
Volume4
Avg Volume141
Beta0.99
Dividend€0.89
Analyst Ratings
No analyst coverage
Company Info
CEOMatthieu Frechin
Employees2,519
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2013-03-05
Websitevetoquinol.com
Magny-Vernois
Lure 70204
FR
Lure 70204
FR
33 3 84 62 55 55
About Vetoquinol S.A.
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
Latest News
No recent news
Recent Insider Trades
No insider trades found